Aleta’s approach is based on CD19 CAR T-cell engagers (CTEs), simple but potent proteins designed to enhance the expression of CAR T-cell target antigens on any tumor cell. CTEs contain multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback